proprietary ai-driven platform (VeriSIM Life Inc)
90
Structured Review
VeriSIM Life Inc
proprietary ai-driven platform
Proprietary Ai Driven Platform, supplied by VeriSIM Life Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proprietary+ai-driven+platform/proprietary+ai+driven+platform/pm35313359-257-15-9
Average 90 stars, based on 1 article reviews
Proprietary Ai Driven Platform, supplied by VeriSIM Life Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proprietary+ai-driven+platform/proprietary+ai+driven+platform/pm35313359-257-15-9
Average 90 stars, based on 1 article reviews
proprietary ai-driven platform - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: In Silico Development of Combinatorial Therapeutic Approaches Targeting Key Signaling Pathways in Metabolic Syndrome. Article Snippet: Purpose Dysregulations of key signaling pathways in metabolic syndrome are multifactorial, eventually leading to cardiovascular events.. Hyperglycemia in conjunction with dyslipidemia induces insulin resistance and provokes release of proinflammatory cytokines resulting in chronic inflammation, accelerated lipid peroxidation with further development of atherosclerotic alterations and diabetes.. We have proposed a novel combinatorial approach using FDA approved compounds targeting IL-17a and DPP4 to ameliorate a significant portion of the clustered clinical risks in patients with metabolic syndrome. |